Programa de Pós-graduação em Bioquímica, Centro de Biociências, Universidade Federal do Rio Grande do Norte, Natal 59064-741, Brazil.
Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, 2775-412 Oeiras, Portugal.
Int J Mol Sci. 2019 Mar 25;20(6):1484. doi: 10.3390/ijms20061484.
The protozoan , responsible for animal and human trypanosomiasis, has a family of major surface proteases (MSPs) and phospholipase-C (PLC), both involved in some mechanisms of virulence during mammalian infections. During parasitism in the mammalian host, this protozoan is exclusively extracellular and presents a robust mechanism of antigenic variation that allows the persistence of infection. There has been incredible progress in our understanding of how variable surface glycoproteins (VSGs) are organised and expressed, and how expression is switched, particularly through recombination. The objective of this manuscript is to create a reflection about the mechanisms of antigenic variation in , more specifically, in the process of variable surface glycoprotein (VSG) release. We firstly explore the mechanism of VSG release as a potential pathway and target for the development of anti- drugs.
引起动物和人类锥虫病的原生动物有一种主要表面蛋白酶(MSPs)和磷脂酶-C(PLC)家族,这两者都参与了哺乳动物感染过程中的一些毒力机制。在哺乳动物宿主寄生期间,这种原生动物完全在细胞外,具有强大的抗原变异机制,使感染得以持续。我们对可变表面糖蛋白(VSG)的组织和表达方式以及表达如何通过重组切换有了令人难以置信的深入了解。本文的目的是对 中的抗原变异机制进行思考,更具体地说,是在可变表面糖蛋白(VSG)释放过程中进行思考。我们首先探讨了 VSG 释放的机制,将其作为开发抗药物的潜在途径和靶点。